Mackenzie Financial’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Mackenzie Financial’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-18,897	Closed	-$619K	–	791
2014 Q3	$619K	Buy	18,897 +800	+4%	+$28.2K	﹤0.01%	593
2014 Q2	$694K	Sell	18,097 -18,283	-50%	-$638K	﹤0.01%	561
2014 Q1	$1.45M	Sell	36,380 -2,019	-5%	-$90.3K	0.01%	437
2013 Q4	$1.43M	Buy	38,399 +31,061	+423%	+$1.29M	0.01%	429
2013 Q3	$306K	Buy	+7,338	New	+$219K	﹤0.01%	594

Other funds holding KYTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Mackenzie Financial's KYTH Position: Q4 2014 in Review

Mackenzie Financial sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2014, closing a stake of 18,897 shares — an estimated $619K sold.

Mackenzie Financial first reported a position in KYTH in Q3 2013 and held it in 5 quarters. The position peaked at $1.45M in Q1 2014. 106 funds tracked by Wall St. Rank hold KYTH as of Q4 2014.

Mackenzie Financial reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2014 after selling out during the quarter.
Mackenzie Financial sold 18,897 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2014, an estimated $619K.
Mackenzie Financial first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 5 quarters.
Mackenzie Financial's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.45M in Q1 2014.
106 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2014.

Based on Mackenzie Financial's 13F filing for Q4 2014, filed 11 Feb 2015.